Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- mice

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 641-647

  Christoph, Marian ^a   Ibrahim, Karim ^a   Hesse, Kathleen ^a   Augstein, Antje ^a   Schmeisser, Alexander ^a   Braun Dullaeus, Ruediger C ^a   Simonis, Gregor ^a   Wunderlich, Carsten ^a   Quick, Silvio ^a   Strasser, Ruth H ^a   Poitz, David M ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atherosclerosis; Hypoxia; Hypoxia inducible factor; Restenosis

Indexed keywords

APOLIPOPROTEIN E; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; PHOSPHOGLYCERATE KINASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; FLT1 PROTEIN, MOUSE; HIF1A PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE;

ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DEEP FEMORAL ARTERY; DISEASE COURSE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; IN VIVO STUDY; IN-STENT RESTENOSIS; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ADENOVIRIDAE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DEFICIENCY; DISEASE MODEL; FEMORAL ARTERY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; KNOCKOUT MOUSE; PHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC; RESTENOSIS; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEINS E; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CORONARY RESTENOSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; GENETIC VECTORS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, KNOCKOUT; NEOINTIMA; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84896284184     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.048     Document Type: Article

References (45)

1. Dangas G.D., Claessen B.E., Caixeta A., Sanidas E.A., Mintz G.S., Mehran R. In-stent restenosis in the drug-eluting stent era. JAm Coll Cardiol 2010, 56:1897-1907.
2. Gaspardone A., Versaci F. Coronary stenting and inflammation. Am J Cardiol 2005, 96:65L-70L.
3. Davies M.G., Hagen P.O. Pathobiology of intimal hyperplasia. Br J Surg 1994, 81:1254-1269.
4. Sluimer J.C., Gasc J.M., van Wanroij J.L., et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. JAm Coll Cardiol 2008, 51:1258-1265.
5. Szekanecz Z., Besenyei T., Szentpetery A., Koch A.E. Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr Opin Rheumatol 2010, 22:299-306.
6. Li Y., Ye D. Cancer therapy by targeting hypoxia-inducible factor-1. Curr Cancer Drug Targets 2010, 10:782-796.
7. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
8. Bracken C.P., Whitelaw M.L., Peet D.J. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 2003, 60:1376-1393.
9. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995, 92:5510-5514.
10. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. JBiol Chem 1995, 270:1230-1237.
11. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004, 5:343-354.
12. Wiesener M.S., Turley H., Allen W.E., et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998, 92:2260-2268.
13. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. Anovel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 1997, 94:4273-4278.
14. Gu Y.Z., Moran S.M., Hogenesch J.B., Wartman L., Bradfield C.A. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 1998, 7:205-213.
15. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by Metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008, 30:393-402.
16. Miyata T., Takizawa S., van Ypersele de Strihou C. Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets. Am J Physiol Cell Physiol 2011, 300:C226-C231.
17. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 2010, 86:236-242.
18. Sluimer J.C., Daemen M.J. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. JPathol 2009, 218:7-29.
19. Roque M., Fallon J.T., Badimon J.J., Zhang W.X., Taubman M.B., Reis E.D. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol 2000, 20:335-342.
20. Shagdarsuren E., Bidzhekov K., Mause S.F., et al. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 2010, 122:1026-1036.
21. Augstein A., Poitz D.M., Braun-Dullaeus R.C., Strasser R.H., Schmeisser A. Cell-specific and hypoxia-dependent regulation of human HIF-3alpha: inhibition of the expression of HIF target genes in vascular cells. Cell Mol Life Sci 2011, 68:2627-2642.
22. Jing D., Wobus M., Poitz D.M., Bornhauser M., Ehninger G., Ordemann R. Oxygen tension plays a critical role in the hematopoietic microenvironment invitro. Haematologica 2012, 97:331-339.
23. Maemura K., Hsieh C.M., Jain M.K., et al. Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. JBiol Chem 1999, 274:31565-31570.
24. Poitz D.M., Augstein A., Weinert S., Braun-Dullaeus R.C., Strasser R.H., Schmeisser A. OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway. Basic Res Cardiol 2011, 106:761-772.
25. Hoffmann R., Mintz G.S. Coronary in-stent restenosis - predictors, treatment and prevention. Eur Heart J 2000, 21:1739-1749.
26. Stone G.W., Ellis S.G., Cox D.A., et al. Apolymer-based, paclitaxel-eluting stent in patients with coronary artery disease. NEngl J Med 2004, 350:221-231.
27. Bjornheden T., Levin M., Evaldsson M., Wiklund O. Evidence of hypoxic areas within the arterial wall invivo. Arterioscler Thromb Vasc Biol 1999, 19:870-876.
28. Luque A., Turu M., Juan-Babot O., et al. Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques. Front Biosci 2008, 13:6483-6490.
29. Bitto A., De Caridi G., Polito F., et al. Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques. JVasc Surg 2010, 52:1015-1021.
30. Ben-Shoshan J., Afek A., Maysel-Auslender S., et al. HIF-1alpha overexpression and experimental murine atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29:665-670.
31. Karshovska E., Zernecke A., Sevilmis G., et al. Expression of HIF-1 in injured arteries controls SDF-1 mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:2540-2547.
32. Semenza G.L. Oxygen sensing, homeostasis, and disease. NEngl J Med 2011, 365:537-547.
33. Deguchi Jo, Yamazaki H., Aikawa E., Aikawa M. Chronic hypoxia Activates the Akt and -Catenin pathways in human macrophages. Arterioscler Thromb Vasc Biol 2009, 29:1664-1670.
34. Castellano J., Aledo R., Sendra J., et al. Hypoxia stimulates low-density lipoprotein receptor-related protein-1 expression through hypoxia-inducible factor-1alpha in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2011, 31:1411-1420.
35. Osada-Oka M., Ikeda T., Akiba S., Sato T. Hypoxia stimulates the autocrine regulation of migration of vascular smooth muscle cells via HIF-1alpha-dependent expression of thrombospondin-1. JCell Biochem 2008, 104:1918-1926.
36. Simiantonaki N., Jayasinghe C., Michel-Schmidt R., Peters K., Hermanns M.I., Kirkpatrick C.J. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines. Int J Oncol 2008, 32:585-592.
37. Schmeisser A., Christoph M., Augstein A., et al. Apoptosis of human macrophages by Flt-4 signaling: implications for atherosclerotic plaque pathology. Cardiovasc Res 2006, 71:774-784.
38. Page E.L., Robitaille G.A., Pouyssegur J., Richard D.E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. JBiol Chem 2002, 277:48403-48409.
39. Vink A., Schoneveld A.H., Lamers D., et al. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis 2007, 195:e69-75.
40. Chen F., Eriksson P., Kimura T., Herzfeld I., Valen G. Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque. Coron Artery Dis 2005, 16:191-197.
41. Osada-Oka M., Ikeda T., Imaoka S., Akiba S., Sato T. VEGF-enhanced proliferation under hypoxia by an autocrine mechanism in human vascular smooth muscle cells. JAtheroscler Thromb 2008, 15:26-33.
42. Bhardwaj S., Roy H., Heikura T., Yla-Herttuala S. VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries. Eur J Clin Invest 2005, 35:669-676.
43. Koga J., Matoba T., Egashira K., et al. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice. Arterioscler Thromb Vasc Biol 2009, 29:458-464.
44. Khurana R., Zhuang Z., Bhardwaj S., et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 2004, 110:2436-2443.
45. Simons M. VEGF and restenosis: the rest of the story. Arterioscler Thromb Vasc Biol 2009, 29:439-440.